Rosuvastatin: all 482 studies that test it
Page 5 of 5. Open to participants first (32), then studies with results posted, then the rest; newest registration first within each.
- Rosuvastatin for Preventing Deep Vein ThrombosisStatus unknownNCT01021488Phase 4
- Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed HyperlipidemiaStatus unknownNCT01010516Phase 4
- Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs)CompletedNCT01007279Phase 3
- Statin and Atheroma Vulnerability EvaluationCompletedNCT00997880Phase 4
- Effect of Rosuvastatin on Cytokines After Traumatic Brain InjuryCompletedNCT00990028Phase 1/2
- Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion InjuryCompletedNCT00987974Phase 4
- Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary HypertensionCompletedNCT00984932Phase 3
- Tolerability and Lipid Lowering Effect of Weekly/Biweekly Crestor in Statin Intolerant Patients Treated With ZetiaStatus unknownNCT00972829Phase 4
- Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLCCompletedNCT00966472Phase 1
- Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin TherapyWithdrawnNCT00951132Phase 2
- Treatment of Hyperlipidemia and Sexual DysfunctionStatus unknownNCT00923676Phase 4
- Effect of Rosuvastatin on Endothelial Function in Patients With Diabetes and GlaucomaWithdrawnNCT00913562Phase 4
- Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH)Status unknownNCT00885872Phase 4
- Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol LevelStatus unknownNCT00866229Phase 4
- Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic PatientsCompletedNCT00854503Phase 3
- Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated?CompletedNCT00851175Phase 4
- A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat MalariaTerminatedNCT00811356Phase 1
- Effects of Rosuvastatin on Aortic Stenosis ProgressionCompletedNCT00800800Phase 3
- Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With DiabetesCompletedNCT00786136Phase 4
- Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function MeasurementsCompletedNCT00783042Early Phase 1
- Study in Taiwanese Subjects Identified as CYP2C19 Poor and Extensive Metabolizers Receiving RosuvastatinCompletedNCT00766025Phase 1
- Effect of Homocysteine-lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Endothelium-dependent Vasodilatation of Forearm Resistance Vessels in Patients With Coronary Heart DiseaseCompletedNCT00693589Phase 2
- Effects of Crestor on Inflammation of Atherosclerotic PlaquesCompletedNCT00689416Early Phase 1
- Rosuvastatin in Rheumatoid Arthritis (RORA)CompletedNCT00679510Phase 2/3
- Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive PatientsTerminatedNCT00673582Phase 4
- Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic PatientsCompletedNCT00658463Phase 4
- Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery DiseaseCompletedNCT00657527Phase 3
- 48-wk Open Label Phase IIIb to Evaluate Efficacy and SafetyCompletedNCT00654602Phase 3
- STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose RangesCompletedNCT00654537Phase 3
- COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome SubjectsCompletedNCT00654485Phase 3
- IIIb 6 Week Open Label Multicentre Rosuvastatin & SimvastatinCompletedNCT00654446Phase 3
- Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb HypercholesterolemiaCompletedNCT00654407Phase 3
- Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic SubjectsCompletedNCT00654394Phase 3
- OLE Study to Evaluate Safety / Efficacy of ZD4522CompletedNCT00654303Phase 3
- Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)CompletedNCT00654225Phase 3
- Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR)CompletedNCT00654173Phase 3
- Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)CompletedNCT00653965Phase 3
- Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)CompletedNCT00653744Phase 3
- Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 WeeksCompletedNCT00653588Phase 3
- Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)TerminatedNCT00651378Phase 4
- Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)CompletedNCT00651144Phase 1
- Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered ConcomitantlyCompletedNCT00585143Phase 1
- Effects of HMG-coA Reductase Inhibitor on Rheumatoid ArthritisCompletedNCT00555230Phase 2
- The Effect of Rosuvastatin on Adenosine MetabolismCompletedNCT00554138Not applicable
- Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With DyslipidemiaCompletedNCT00506961Phase 4
- Effect of Rosuvastatin on Left Ventricular RemodelingCompletedNCT00505154Phase 3
- Interaction Between ABT-335, Rosuvastatin and WarfarinCompletedNCT00487136Phase 1
- Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?CompletedNCT00457652Phase 4
- Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis CCompletedNCT00446940Phase 2
- ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL GoalsWithdrawnNCT00396240Phase 4
- Rosuvastatin ORBITAL GermanyCompletedNCT00379249Phase 3
- Rosuvastatin for Hepatitis CWithdrawnNCT00371579Not applicable
- Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus ErythematosusCompletedNCT00371501Phase 4
- Effect of Rosuvastatin in Intracerebral HemorrhageCompletedNCT00364559Phase 2
- Effect of Rosuvastatin in Abdominal SepsisStatus unknownNCT00357123Phase 2
- Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy SubjectsCompletedNCT00344123Phase 1
- GISSI-HF- Effects of n-3 PUFA and Rosuvastatin on Mortality-Morbidity of Patients With Symptomatic CHFCompletedNCT00336336Phase 3
- Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic SyndromeCompletedNCT00335699Phase 4
- Effect of Rosuvastatin on Amnesia and Orientation Through Galveston Outcome Amnesia Test in Moderate Head InjuryCompletedNCT00329758Phase 2
- PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.CompletedNCT00329173Phase 3
- Rosuvastatin and Ischemia ReperfusionCompletedNCT00315510Phase 2
- Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary SyndromeCompletedNCT00296387Phase 3
- Exercise And Rosuvastatin Treatment: Is There an Anti-Inflammatory Synergy?Status unknownNCT00295373Phase 4
- Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With HypercholesterolemiaCompletedNCT00249912Phase 3
- DISCOVERY Asia - Crestor in Type IIa and IIb HypercholesteremiaCompletedNCT00241488Phase 3
- A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)CompletedNCT00240318Phase 3
- A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic SyndromeCompletedNCT00240305Phase 3
- Rosuvastatin Impact on Ventricular Remodelling Lipids and CytokinesCompletedNCT00240292Phase 3
- The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA StudyCompletedNCT00240279Phase 3
- Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)CompletedNCT00240266Phase 3
- Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin TherapyCompletedNCT00239330Phase 3
- Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart DiseaseCompletedNCT00235950Phase 4
- Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub StudyCompletedNCT00228514Phase 3
- A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)CompletedNCT00225589Phase 3
- Type III DysbetalipoproteinemiaCompletedNCT00214604Phase 3
- Crestor Versus Placebo in Subjects With Heart FailureCompletedNCT00206310Phase 3
- Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV PatientsCompletedNCT00184951Phase 2
- Impact of Rosuvastatin on Endothelial Function and Inflammation in Patients With Chronic Heart FailureCompletedNCT00176332Phase 2
- Rosuvastatin and Renal Endothelial FunctionCompletedNCT00160745Phase 2
- Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)CompletedNCT00117494Phase 4
- Rho Kinase in Patients With AtherosclerosisCompletedNCT00115830Phase 3
- Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)CompletedNCT00090298Phase 3